Search research articles
Contact Us
Filters
Showing results (431-440 of 441) with videos related to
Page
of 45
Sort By:
Clinical Immunology (Orlando, Fla.)
|
September 16, 2018
Safety profile after prolonged C3 inhibition
Edimara S Reis, Nadja Berger, Xin Wang, et al.
Nature Immunology
|
September 29, 2019
'Stealth' corporate innovation: an emerging threat for therapeutic drug development
Dimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Clinical Immunology (Orlando, Fla.)
|
September 22, 2020
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
Dimitrios C Mastellos, Bruno G P Pires da Silva, Benedito A L Fonseca, et al.
Infection
|
August 15, 2018
Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis
Marcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
Shock (Augusta, Ga.)
|
August 15, 2018
Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International Expert Consensus Initiative for Improvement of Animal Modeling in Sepsis
Marcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
Intensive Care Medicine Experimental
|
August 17, 2018
Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis
Marcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
Infection
|
September 19, 2018
Correction to: Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis
Marcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
The Journal of Clinical Investigation
|
October 16, 2018
Thirty-eight-negative kinase 1 mediates trauma-induced intestinal injury and multi-organ failure
Milena Armacki, Anna Katharina Trugenberger, Ann K Ellwanger, et al.
Science Advances
|
August 17, 2022
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101
Panagiotis Skendros, Georgios Germanidis, Dimitrios C Mastellos, et al.
Biomaterials
|
March 31, 2018
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial
Enrique Gómez-Barrena, Philippe Rosset, Florian Gebhard, et al.
Page
of 45
Search research articles
Search
Showing results (431-440 of 441) with videos related to
Sort By:
Page
of 45
Clinical Immunology (Orlando, Fla.)
|
September 16, 2018
Safety profile after prolonged C3 inhibition
Edimara S Reis, Nadja Berger, Xin Wang, et al.
Nature Immunology
|
September 29, 2019
'Stealth' corporate innovation: an emerging threat for therapeutic drug development
Dimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Clinical Immunology (Orlando, Fla.)
|
September 22, 2020
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
Dimitrios C Mastellos, Bruno G P Pires da Silva, Benedito A L Fonseca, et al.
Infection
|
August 15, 2018
Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis
Marcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
Shock (Augusta, Ga.)
|
August 15, 2018
Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International Expert Consensus Initiative for Improvement of Animal Modeling in Sepsis
Marcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
Intensive Care Medicine Experimental
|
August 17, 2018
Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis
Marcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
Infection
|
September 19, 2018
Correction to: Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis
Marcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
The Journal of Clinical Investigation
|
October 16, 2018
Thirty-eight-negative kinase 1 mediates trauma-induced intestinal injury and multi-organ failure
Milena Armacki, Anna Katharina Trugenberger, Ann K Ellwanger, et al.
Science Advances
|
August 17, 2022
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101
Panagiotis Skendros, Georgios Germanidis, Dimitrios C Mastellos, et al.
Biomaterials
|
March 31, 2018
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial
Enrique Gómez-Barrena, Philippe Rosset, Florian Gebhard, et al.
Page
of 45